A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
HER2 Mutation

Interventions

DRUG: BAY2927088

Sponsor

Bayer